Nisha Pandey

Health and Me

Why Is The US Fast Tracking Trials Of Ibogaine, A Schedule I Controlled Substance, Despite Safety Risks

The US is actively advancing government-funded clinical trials of <span>ibogaine</span>, a psychedelic drug that remains classified as a Schedule I controlled substance and has been linked to several dangerous health effects, including irregular heart rhythm. 

The <span>Food and Drug Administration</span> (<span>FDA</span>) is now seeking public input on how early-stage clinical trials of ibogaine should be designed, including dosing, patient selection, and safety monitoring. 

The move comes after President <span>Donald Trump</span> signed an executive order in April, directing federal agencies to accelerate research into psychedelic drugs for serious mental health conditions. 

The federal government has allocated $50 million for ibogaine research. The first government-funded trials will focus on adults with opioid use disorder (OUD) and <a href="https://www.healthandme.com/health-news/us-fda-to-hold-psychedelic-drug-hearing-amid-trump-push-what-it-means-for-depression-ptsd-article-156157480" data-type="tilCustomLink">post-traumatic stress disorder</a> (PTSD). The research is being supported by the Advanced Research Projects Agency for Health (ARPA-H) and the <span>National Institute on Drug Abuse</span> (NIDA). 

Also read: <a href="https://www.healthandme.com/health-news/fda-links-lettuce-to-cyclospora-outbreak-that-infected-almost-13000-heres-why-mexico-disputes-it-article-156274822" data-type="tilCustomLink">FDA Links Lettuce To Cyclospora Outbreak That Infected Almost 13,000: Here's Why Mexico Disputes It</a>

Ibogaine is a psychoactive compound derived from the iboga shrub, which primarily grows in parts of Central and West Africa. It has sparked interests of scientists and researchers as it is reported to reduce drug cravings and alleviate symptoms of withdrawal. In a nutshell, it has shown benefit in people with opioid and other substance-use disorders. 

Unlike existing <span>addiction</span> treatments, ibogaine can produce a prolonged psychedelic experience and affects several neurological systems. 

Researchers are investigating whether these effects could help alter brain circuits related to <a href="https://www.healthandme.com/health-news/punjab-to-start-screening-for-hiv-hepatitis-b-c-at-de-addiction-centres-article-156277902" data-type="tilCustomLink">addiction</a> and reduce substance use. 

But it must be noted that plenty of this evidence comes from observational studies, open-label research, and small clinical trials. Therefore the FDA is trying to ramp up more evidence rather than introducing the drug directly into widespread medical use. 

<h2>Safety Concerns Related To Ibogaine </h2>

Also read: <a href="https://www.healthandme.com/health-news/after-488-sickened-65-hospitalised-in-salmonella-outbreak-fda-issues-highest-risk-recall-for-salad-dressing-article-156274329" data-type="tilCustomLink">After 488 Sickened &amp; 65 Hospitalised In Salmonella Outbreak, FDA Issues Highest-Risk Recall For Salad Dressing</a>

Ibogaine and its metabolite noribogaine could disrupt the heart's electrical system and prolong the QT interval, a measurement of the time taken for the heart to electrically reset between beats. 

Excessive prolonged QT can trigger dangerous ventricular arrhythmias, including Torsades de Pointes, which can prove to be fatal. 

Although considered rare, a 2026 review published in <em>Addiction</em> found that these cardiac events have occurred at therapeutic doses and even in people without known heart disease. 

<a href="https://www.healthandme.com/health-wellness/world-no-alcohol-day-origins-health-risks-and-what-science-says-about-drinking-article-156260612" data-type="tilCustomLink">Ibogaine</a> could also lead to neurological toxicity. Reuters reported that FDA officials have highlighted both dangerous heart arrhythmias and brain toxicity as risks that need to be better investigated and understood before the drug can be developed more safely. 

<h2>Why US Is Accelerating Research Despite The Risks? </h2>

Alzheimer’s Disease: Early Signs, Symptoms, Diagnosis & Prevention Tips

The FDA's recent request seeks input on dose escalation, clinical settings, cardiac and neurological monitoring, eligibility criteria, stopping rules and independent safety. A proposed starting dose for early-phase studies would not exceed 10 mg/kg. 

The agency has also said that people with serious conditions that have not responded to existing treatments deserve rigorous investigation of new options. 

“Patients facing serious conditions that have not responded to existing treatments deserve rigorous scientific investigation of promising new approaches,” said Michael Davis, MD, PhD, director of the <a href="https://www.healthandme.com/health-news/new-lymphoma-trial-experimental-drug-combination-cuts-progression-or-death-risk-by-51-article-156281280" data-type="tilCustomLink">FDA's Center for Drug Evaluation and Research</a>. 

“With ibogaine, there are important scientific questions as well as serious safety concerns. We are seeking high-quality data and input that can help inform clinical research while putting patient safety first.” 

Ibogaine's Schedule I classification means that under the US federal law it is considered to be most likely be used for abuse and it cannot be currently accepted for medical use.

Items under this category carry extensive restrictions on possession and research. But Schedule I classification does not mean a substance can never be studied. Rather, research of such compounds require regulatory controls and approvals. 

The FDA has already allowed an early-stage study of <span>noribogaine hydrochloride</span>, which is a desrivative of ibogaine, for alcohol use disorder. It means that the regulator is actively seeking to study psychedelic drugs that could have medicinal potential. 

Health Conditions A-Z

health

why-is-the-us-fast-tracking-trials-of-ibogaine-a-schedule-i-controlled-substance-despite-safety-risks

ibogaine

ibogaine s schedule

food and drug administration

addiction

national institute on drug abuse

donald trump

salmonella outbreak

center for drug evaluation

noribogaine hydrochloride

pneumonic-plague-covid-19-rhinovirus-detected-in-russian-lab-workers-contacts-trump-offers-us-help

Pneumonic Plague: COVID-19, Rhinovirus Detected in Russian Lab Worker’s Contacts; Trump Offers US Help

worst-us-measles-outbreak-in-35-years-new-york-declares-emergency-pennsylvania-crosses-1000-cases

Worst US Measles Outbreak In 35 Years: New York Declares Emergency, Pennsylvania Crosses 1,000 Cases

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

The US is actively advancing government-funded clinical trials of ibogaine, a psychedelic drug that remains classified as a Schedule I controlled substance and has been linked to several dangerous health effects, including irregular heart rhythm. The Food and Drug Administration (FDA) is now seeking public input on how early-stage clinical trials of ibogaine should be designed, including dosing, patient selection, and safety monitoring. The move comes after President Donald Trump signed an executive order in April, directing federal agencies to accelerate research into psychedelic drugs for serious mental health conditions. The federal government has allocated $50 million for ibogaine research. The first government-funded trials will focus on adults with opioid use disorder (OUD) and post-traumatic stress disorder (PTSD). The research is being supported by the Advanced Research Projects Agency for Health (ARPA-H) and the National Institute on Drug Abuse (NIDA). Clinical Interest In Ibogaine Also read: FDA Links Lettuce To Cyclospora Outbreak That Infected Almost 13,000: Here's Why Mexico Disputes ItIbogaine is a psychoactive compound derived from the iboga shrub, which primarily grows in parts of Central and West Africa. It has sparked interests of scientists and researchers as it is reported to reduce drug cravings and alleviate symptoms of withdrawal. In a nutshell, it has shown benefit in people with opioid and other substance-use disorders. Unlike existing addiction treatments, ibogaine can produce a prolonged psychedelic experience and affects several neurological systems. Researchers are investigating whether these effects could help alter brain circuits related to addiction and reduce substance use. But it must be noted that plenty of this evidence comes from observational studies, open-label research, and small clinical trials. Therefore the FDA is trying to ramp up more evidence rather than introducing the drug directly into widespread medical use. Safety Concerns Related To Ibogaine Also read: After 488 Sickened & 65 Hospitalised In Salmonella Outbreak, FDA Issues Highest-Risk Recall For Salad DressingIbogaine and its metabolite noribogaine could disrupt the heart's electrical system and prolong the QT interval, a measurement of the time taken for the heart to electrically reset between beats. Excessive prolonged QT can trigger dangerous ventricular arrhythmias, including Torsades de Pointes, which can prove to be fatal. Although considered rare, a 2026 review published in Addiction found that these cardiac events have occurred at therapeutic doses and even in people without known heart disease. Ibogaine could also lead to neurological toxicity. Reuters reported that FDA officials have highlighted both dangerous heart arrhythmias and brain toxicity as risks that need to be better investigated and understood before the drug can be developed more safely. Why US Is Accelerating Research Despite The Risks?             The FDA's recent request seeks input on dose escalation, clinical settings, cardiac and neurological monitoring, eligibility criteria, stopping rules and independent safety. A proposed starting dose for early-phase studies would not exceed 10 mg/kg. The agency has also said that people with serious conditions that have not responded to existing treatments deserve rigorous investigation of new options. “Patients facing serious conditions that have not responded to existing treatments deserve rigorous scientific investigation of promising new approaches,” said Michael Davis, MD, PhD, director of the FDA's Center for Drug Evaluation and Research. “With ibogaine, there are important scientific questions as well as serious safety concerns. We are seeking high-quality data and input that can help inform clinical research while putting patient safety first.” Ibogaine's Schedule I classification means that under the US federal law it is considered to be most likely be used for abuse and it cannot be currently accepted for medical use.Items under this category carry extensive restrictions on possession and research. But Schedule I classification does not mean a substance can never be studied. Rather, research of such compounds require regulatory controls and approvals. The FDA has already allowed an early-stage study of noribogaine hydrochloride, which is a desrivative of ibogaine, for alcohol use disorder. It means that the regulator is actively seeking to study psychedelic drugs that could have medicinal potential. 

why is the us fast tracking trials of ibogaine, a schedule i controlled substance, despite safety risks

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Why Is The US Fast Tracking Trials Of Ibogaine, A Schedule I Controlled Substance, Despite Safety Risks

Pneumonic Plague: COVID-19, Rhinovirus Detected in Russian Lab Worker’s Contacts; Trump Offers US Help

Worst US Measles Outbreak In 35 Years: New York Declares Emergency, Pennsylvania Crosses 1,000 Cases

New Lymphoma Trial: Experimental Drug Combination Cuts Progression Or Death Risk By 51%

Health Conditions A-Z

Why Is The US Fast Tracking Trials Of Ibogaine, A Schedule I Controlled Substance, Despite Safety Risks

Pneumonic Plague: COVID-19, Rhinovirus Detected in Russian Lab Worker’s Contacts; Trump Offers US Help

Worst US Measles Outbreak In 35 Years: New York Declares Emergency, Pennsylvania Crosses 1,000 Cases